+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032- Product Image
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032- Product Image
Sale

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127400
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nuclear Medicine & Radiopharmaceuticals Market is projected to reach USD 10.07 Billion in 2026. It is expected to continue growing at a CAGR of 6.83%, reaching USD 15.12 Billion by 2032.

Nuclear Medicine and Radiopharmaceuticals: Executive Overview

Nuclear medicine and radiopharmaceuticals support diagnosis, disease staging, treatment planning, and targeted therapy by combining radioactive substances with imaging or biologically active molecules. The field is shaped by clinical demand for earlier detection, more precise treatment selection, and improved monitoring across oncology, cardiology, neurology, and other specialties. Its development depends on reliable isotope production, radiochemistry capacity, specialized equipment, trained personnel, regulatory oversight, and coordinated clinical pathways.

Transformative Shifts Reshaping Nuclear Medicine

The landscape is moving from predominantly diagnostic applications toward integrated diagnostic-and-therapeutic approaches, including theranostics that use related agents to identify and treat disease. Advances in detector technology, hybrid imaging, radiochemistry, dosimetry, and decentralized preparation are improving clinical workflow and personalization. At the same time, short isotope half-lives, stringent handling requirements, limited production capacity, and complex cross-border logistics continue to make supply resilience and quality assurance central strategic priorities.

Artificial Intelligence Expands Precision and Operational Capability

Artificial intelligence is being applied to image reconstruction, lesion detection, segmentation, quantitative analysis, treatment response assessment, and workflow prioritization. It can help reduce interpretation variability and support more consistent dosimetry when trained and validated on representative clinical data. Effective adoption requires explainable outputs, prospective clinical validation, cybersecurity, interoperability with imaging and hospital systems, and governance that preserves clinician accountability rather than treating algorithmic results as autonomous decisions.

Regional Insights: Uneven Capacity with Broad Clinical Opportunity

North America combines advanced imaging infrastructure, specialized therapeutic programs, and established regulatory pathways, while continuing to address workforce and isotope-supply constraints. Europe benefits from strong academic networks and coordinated research activity, but access varies across health systems and national reimbursement frameworks. Asia-Pacific includes highly capable systems alongside rapidly developing capacity, creating substantial differences in availability, training, and radiopharmaceutical production. The Middle East is investing in advanced healthcare infrastructure and specialist centers, whereas Africa faces greater constraints in equipment, isotope access, and trained personnel. Latin America is expanding specialized services, with progress influenced by import dependence, public-sector capacity, and uneven geographic access.

Group Insights: Cooperation, Regulation, and Supply Resilience

ASEAN countries are pursuing broader healthcare modernization, but nuclear medicine access differs significantly among members and depends on regional training and supply partnerships. BRICS economies combine major research and manufacturing capabilities with varied regulatory systems and uneven access within countries. The European Union emphasizes cross-border research, harmonized standards, and coordinated health initiatives, while national implementation remains diverse. G7 members generally possess mature clinical and scientific ecosystems but face aging infrastructure, workforce shortages, and pressure to improve affordability. GCC states are strengthening specialist healthcare capacity through centralized investment and international collaboration. NATO members show varied national capabilities, while alliance-wide preparedness and logistics considerations reinforce the importance of resilient medical isotope supply chains.

Country Insights: Distinct Capabilities and Development Priorities

Australia has established nuclear science capabilities and supports specialized clinical services across a geographically dispersed population. Brazil is developing access amid regional inequality and infrastructure constraints. Canada combines strong research institutions with logistical challenges associated with distance and isotope distribution. China is expanding clinical capacity, domestic production, and advanced oncology applications. France and Germany maintain sophisticated hospital and research networks, while Italy and Spain continue strengthening specialized services within diverse regional health systems. India is broadening access through major medical centers and growing radiopharmaceutical expertise, although availability remains uneven. Japan and South Korea have advanced imaging and clinical research capabilities, with continued attention to aging populations and treatment innovation. Mexico is expanding specialist services while addressing infrastructure and workforce gaps. Russia retains scientific and nuclear-sector capabilities, with access and supply conditions shaped by regulatory and geopolitical factors. The United Kingdom and United States have mature clinical ecosystems, but both must manage workforce requirements, production resilience, evidence generation, and equitable patient access.

Strategic Priorities for Industry Leaders and Healthcare Systems

Leaders should prioritize resilient isotope sourcing, redundant logistics, validated quality systems, and closer coordination among producers, regulators, hospitals, and nuclear pharmacies. Investment should focus on therapies and imaging agents supported by clear clinical evidence, practical dosimetry, and workflows that can be implemented beyond highly specialized centers. Organizations should build multidisciplinary training programs, strengthen patient-selection and follow-up protocols, and use real-world evidence to demonstrate clinical value. AI initiatives should begin with high-value, auditable use cases and include bias testing, cybersecurity, interoperability, and post-deployment monitoring. Regional partnerships can improve access by sharing expertise, standardizing procedures, and supporting local production or preparation where technically and legally appropriate.

Research Methodology for the Executive Summary

This summary uses the defined nuclear medicine and radiopharmaceuticals market scope and synthesizes verified, non-estimative insights across clinical practice, isotope production, radiochemistry, imaging technology, regulation, infrastructure, workforce, and supply-chain conditions. Regional, group, and country observations are framed comparatively and qualitatively rather than through market sizing or forecasting. The assessment distinguishes established capabilities from emerging priorities and emphasizes evidence-based themes that are broadly relevant across diagnostic and therapeutic applications. Interpretation should be complemented by current regulatory documents, clinical guidelines, peer-reviewed studies, health-system data, and local access assessments before investment or policy decisions are made.

Conclusion: Building a More Precise and Resilient Nuclear Medicine Ecosystem

Nuclear medicine and radiopharmaceuticals are evolving toward more integrated, personalized, and therapeutically consequential care. Progress will depend not only on scientific breakthroughs but also on dependable isotope supply, specialized skills, rigorous evidence, responsible AI, and equitable delivery infrastructure. Organizations that align innovation with operational resilience and clinical value will be better positioned to expand appropriate use while maintaining safety, quality, and patient-centered care across diverse health systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Nuclear Medicine & Radiopharmaceuticals Market, by Product Type
7.1. Introduction
7.2. Diagnostic Radiopharmaceuticals
7.2.1. PET Radiopharmaceuticals
7.2.1.1. F-18 Radiopharmaceuticals
7.2.1.2. Ga-68 Radiopharmaceuticals
7.2.2. SPECT Radiopharmaceuticals
7.2.2.1. Non Tc-99m Radiopharmaceuticals
7.2.2.2. Tc-99m Radiopharmaceuticals
7.3. Therapeutic Radiopharmaceuticals
7.3.1. Alpha Emitting Radiopharmaceuticals
7.3.2. Beta Emitting Radiopharmaceuticals
7.3.2.1. I-131 Based Therapies
7.3.2.2. Lu-177 Based Therapies
7.3.2.3. Y-90 Based Therapies
8. Nuclear Medicine & Radiopharmaceuticals Market, by Isotope Type
8.1. Introduction
8.2. Cyclotron Produced Isotopes
8.2.1. C-11
8.2.2. F-18
8.3. Generator Based Isotopes
8.3.1. Ge-68 Ga-68 Generators
8.3.2. Mo-99 Tc-99m Generators
9. Nuclear Medicine & Radiopharmaceuticals Market, by Application
9.1. Introduction
9.2. Bone Imaging
9.3. Cardiology
9.4. Inflammation Imaging
9.5. Neurology
9.6. Oncology
10. Nuclear Medicine & Radiopharmaceuticals Market, by End User
10.1. Introduction
10.2. Ambulatory Care Facilities
10.3. Diagnostic Imaging Centers
10.4. Hospital Radiology Departments
10.5. Research Organizations
11. Nuclear Medicine & Radiopharmaceuticals Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Nuclear Medicine & Radiopharmaceuticals Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Nuclear Medicine & Radiopharmaceuticals Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Nuclear Medicine & Radiopharmaceuticals Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Advanced Accelerator Applications S.A.
16.2. AstraZeneca PLC
16.3. Bayer AG
16.4. Bracco Imaging S.p.A.
16.5. Bristol-Myers Squibb Company
16.6. BWX Technologies, Inc.
16.7. Cardinal Health, Inc.
16.8. Clarity Pharmaceuticals Ltd.
16.9. Curium Pharma
16.10. Eckert & Ziegler SE
16.11. Eli Lilly and Company
16.12. GE HealthCare Technologies Inc.
16.13. Ion Beam Applications S.A.
16.14. ITM Isotope Technologies Munich SE
16.15. Jubilant Pharmova Limited
16.16. Lantheus Holdings, Inc.
16.17. NorthStar Medical Radioisotopes, LLC
16.18. Novartis AG
16.19. Siemens Healthineers AG
16.20. Telix Pharmaceuticals Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Nuclear Medicine & Radiopharmaceuticals Market, Years Considered for the Study
FIGURE 2. Global Nuclear Medicine & Radiopharmaceuticals Market, Research Design
FIGURE 3. Global Nuclear Medicine & Radiopharmaceuticals Market, Research Framework
FIGURE 4. Global Nuclear Medicine & Radiopharmaceuticals Market, Data Triangulation
FIGURE 5. Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2025 vs 2032 (%)
FIGURE 9. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Nuclear Medicine & Radiopharmaceuticals Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Nuclear Medicine & Radiopharmaceuticals Market Segmentation & Coverage
TABLE 2. Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Diagnostic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Diagnostic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Diagnostic Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global PET Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global PET Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global PET Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global F-18 Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global F-18 Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global F-18 Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Ga-68 Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Ga-68 Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Ga-68 Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global SPECT Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global SPECT Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global SPECT Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Non Tc-99m Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Non Tc-99m Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Non Tc-99m Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Tc-99m Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Tc-99m Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Tc-99m Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Therapeutic Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Therapeutic Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Therapeutic Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Alpha Emitting Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Alpha Emitting Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Alpha Emitting Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Beta Emitting Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Beta Emitting Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Beta Emitting Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global I-131 Based Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global I-131 Based Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global I-131 Based Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Lu-177 Based Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Lu-177 Based Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Lu-177 Based Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Y-90 Based Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Y-90 Based Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Y-90 Based Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 44. Global Cyclotron Produced Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Cyclotron Produced Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Cyclotron Produced Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global C-11 Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global C-11 Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global C-11 Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global F-18 Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global F-18 Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global F-18 Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Generator Based Isotopes Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Generator Based Isotopes Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Generator Based Isotopes Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Ge-68 Ga-68 Generators Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Ge-68 Ga-68 Generators Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Ge-68 Ga-68 Generators Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Mo-99 Tc-99m Generators Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Mo-99 Tc-99m Generators Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Mo-99 Tc-99m Generators Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 63. Global Bone Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Bone Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Bone Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Inflammation Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Inflammation Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Inflammation Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Global Ambulatory Care Facilities Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Ambulatory Care Facilities Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Ambulatory Care Facilities Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Hospital Radiology Departments Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Hospital Radiology Departments Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Hospital Radiology Departments Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 115. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 116. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 117. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 118. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 119. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 120. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 121. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 122. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. North America Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 128. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 129. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 130. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 131. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 132. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 133. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 134. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 135. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Latin America Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 141. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 142. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 143. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 144. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 145. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 146. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 147. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 148. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. Europe Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 154. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 155. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 156. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 157. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 158. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 159. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 160. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 161. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Middle East Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 167. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 168. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 169. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 170. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 171. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 172. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 173. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 174. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Africa Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 180. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 181. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 182. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 183. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 184. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 185. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 186. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 187. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 188. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. ASEAN Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 194. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 195. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 196. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 197. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 198. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 199. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 200. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 201. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. GCC Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 207. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 208. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 209. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 210. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 211. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 212. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 213. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 214. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. European Union Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 220. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 221. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 222. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 223. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 224. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 225. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 226. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 227. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. BRICS Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 231. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 233. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 234. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 235. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 236. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 237. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 238. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 239. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 240. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. G7 Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 246. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 247. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 248. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 249. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 250. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 251. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 252. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 253. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. NATO Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 256. Global Nuclear Medicine & Radiopharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 257. United States Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 258. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 260. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 261. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 262. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 263. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 264. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 265. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 266. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 267. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. United States Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 271. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 273. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 274. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 275. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 276. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 277. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 278. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 279. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 280. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. Canada Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 283. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2032 (USD Million)
TABLE 284. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 285. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Diagnostic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 286. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by PET Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 287. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by SPECT Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 288. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Therapeutic Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 289. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Beta Emitting Radiopharmaceuticals, 2017-2032 (USD Million)
TABLE 290. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Isotope Type, 2017-2032 (USD Million)
TABLE 291. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Cyclotron Produced Isotopes, 2017-2032 (USD Million)
TABLE 292. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Generator Based Isotopes, 2017-2032 (USD Million)
TABLE 293. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 296. Brazil Nuclear Medicin

Companies Mentioned

  • Advanced Accelerator Applications S.A.
  • AstraZeneca PLC
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Bristol-Myers Squibb Company
  • BWX Technologies, Inc.
  • Cardinal Health, Inc.
  • Clarity Pharmaceuticals Ltd.
  • Curium Pharma
  • Eckert & Ziegler SE
  • Eli Lilly and Company
  • GE HealthCare Technologies Inc.
  • Ion Beam Applications S.A.
  • ITM Isotope Technologies Munich SE
  • Jubilant Pharmova Limited
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Novartis AG
  • Siemens Healthineers AG
  • Telix Pharmaceuticals Limited

Related Topics

Related Reports

Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Nuclear Medicine (Radiopharmaceuticals) - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Nuclear Medicine (Radiopharmaceuticals) - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Radiopharmaceutical CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Radiopharmaceutical CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Radiopharmaceutical Supply Chain Market - Strategic Insights and Forecasts (2026-2031) - Product Image

Radiopharmaceutical Supply Chain Market - Strategic Insights and Forecasts (2026-2031)

  • Report
  • 156 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.